Robert J. Calcaterra
Directeur/Bestuurslid bij Moleculera Labs, Inc.
Profiel
Robert J.
Calcaterra is currently a Director at Moleculera Labs, Inc., Euclises Pharmaceuticals, Inc., Immunovalent Therapeutics, Inc., and Principal at Startup Midwest Management LLC.
He was previously President & CEO at Nidus Center for Scientific Enterprise, Director-Licensing, Research & Development at Adolph Coors Co., Director at Cardialen, Inc. and Galera Therapeutics, Inc., Research Engineer at Monsanto Co., and Senior Research Engineer at Amoco Corp.
He also served as President of St. Louis Arch Angels.
Calcaterra received his undergraduate and graduate degrees from the University of Nebraska and his doctorate from the University of Washington.
Actieve functies van Robert J. Calcaterra
Bedrijven | Functie | Begin |
---|---|---|
Startup Midwest Management LLC | Corporate Officer/Principal | - |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Directeur/Bestuurslid | - |
Moleculera Labs, Inc.
Moleculera Labs, Inc. Medical/Nursing ServicesHealth Services Moleculera Labs, Inc. provides clinical testing services for children and families suspected of suffering from Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS)/Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders, and sometimes Autism Spectrum Disorders. It offers its services to the physician as an aid in their diagnosis of PANDAS/PANS/Childhood Acute Neuropsychiatric Symptoms in parts of the United States. The company was founded by Madeleine Cunningham and Craig Shimasaki in 2011 and is headquartered in Oklahoma City, OK. | Directeur/Bestuurslid | - |
Immunovalent Therapeutics, Inc.
Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Robert J. Calcaterra
Bedrijven | Functie | Einde |
---|---|---|
Nidus Center for Scientific Enterprise
Nidus Center for Scientific Enterprise Miscellaneous Commercial ServicesCommercial Services Nidus Center for Scientific Enterprise provided business development services. The company was headquartered in St. Louis, MO. | Algemeen Directeur | 01-01-2008 |
St. Louis Arch Angels
St. Louis Arch Angels Investment ManagersFinance St. Louis Arch Angels provides seed and early stage capital to the startup organizations. Its members mentor and coach, serve on boards, provide contacts, assist with team building, strategic planning and fundraising. The company was founded by Gilbert Bickel in January 2005 and is headquartered in Saint Louis, MO. | President | - |
Amoco Corp. | Corporate Officer/Principal | - |
Adolph Coors Co. | Hoofd Techniek/Wetenschap/O&O | - |
MONSANTO | Corporate Officer/Principal | - |
Opleiding van Robert J. Calcaterra
University of Nebraska | Graduate Degree |
University of Washington | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GALERA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
Adolph Coors Co. | Consumer Non-Durables |
Monsanto Co.
Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
Cardialen, Inc.
Cardialen, Inc. Medical SpecialtiesHealth Technology Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO. | Health Technology |
Moleculera Labs, Inc.
Moleculera Labs, Inc. Medical/Nursing ServicesHealth Services Moleculera Labs, Inc. provides clinical testing services for children and families suspected of suffering from Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infections (PANDAS)/Pediatric Acute-onset Neuropsychiatric Syndrome (PANS), which are treatable neurologic conditions that may be associated with motor tics, obsessive compulsive disorders, and sometimes Autism Spectrum Disorders. It offers its services to the physician as an aid in their diagnosis of PANDAS/PANS/Childhood Acute Neuropsychiatric Symptoms in parts of the United States. The company was founded by Madeleine Cunningham and Craig Shimasaki in 2011 and is headquartered in Oklahoma City, OK. | Health Services |
Euclises Pharmaceuticals, Inc.
Euclises Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Euclises Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops a portfolio of COX-2 inhibitors optimized for cancer treatment based on its proprietary Euclicoxib platform and is in the process of selecting a lead clinical development candidate. The company was founded by John J. Talley in 2011 and is headquartered in St. Louis, MO. | Health Services |
Amoco Corp. | Energy Minerals |
Nidus Center for Scientific Enterprise
Nidus Center for Scientific Enterprise Miscellaneous Commercial ServicesCommercial Services Nidus Center for Scientific Enterprise provided business development services. The company was headquartered in St. Louis, MO. | Commercial Services |
St. Louis Arch Angels
St. Louis Arch Angels Investment ManagersFinance St. Louis Arch Angels provides seed and early stage capital to the startup organizations. Its members mentor and coach, serve on boards, provide contacts, assist with team building, strategic planning and fundraising. The company was founded by Gilbert Bickel in January 2005 and is headquartered in Saint Louis, MO. | Finance |
Startup Midwest Management LLC | |
Immunovalent Therapeutics, Inc.
Immunovalent Therapeutics, Inc. BiotechnologyHealth Technology Immunovalent Therapeutics, Inc. is a medicine company harnessing microfluidic technology for the treatment of cancer immunotherapy. The company is headquartered in St. Louis, MO. | Health Technology |